Health-Related Quality of Life after Ischemic Stroke: The Impact of Pharmaceutical Interventions on Drug Therapy (Pharmaceutical Care Concept)

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  Hohmann, Carina ^a   Radziwill, Roland ^a   Klotz, Juergen M ^a   Jacobs, Andreas H ^b  

^a KLINIKUM FULDA   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; HEALTH EDUCATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PHARMACEUTICAL CARE; PHARMACY; QUALITY OF LIFE; SHORT FORM 36; TRANSIENT ISCHEMIC ATTACK; CLINICAL TRIAL; FOLLOW UP; GERMANY; HEALTH CARE QUALITY; HEALTH SURVEY; MIDDLE AGED; RISK FACTOR; STROKE;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEALTH STATUS INDICATORS; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; QUALITY ASSURANCE, HEALTH CARE; QUALITY OF LIFE; RISK FACTORS; STROKE;

EID: 77953638851     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-59     Document Type: Article

References (18)

1. Kolominsky-Rabas P, Sarti C, Heuschmann PU, Graf C, Siemonsen S, Neundoerfer B, Katalinic A, Lang E, Gassmann KG, Ritter von Stockert T. A prospective community-based study of stroke in Germany - The Erlangen stroke project (ESPro) - Incidence and case fatality at 1, 3, and 12 months. Stroke 1998, 29:2501-2506.
2. Manolio TA, Kronmal RA, Burke GL, O'Leary DH, Price TH. Short-term predictors of incident stroke in older adults: The Cardiovascular Health study. Stroke 1996, 27:1479-1486.
3. Carod-Artal J, Egido JA, González JL, de Seijas EV. Quality of life among stroke survivors evaluated 1 year after stroke: Experience of a stroke unit. Stroke 2000, 31:2995-3000.
4. de Haan R. Measuring quality of life after stroke using the SF-36. Stroke 2002, 33:1176-1177. 10.1161/01.STR.0000015223.98452.97, 11988583.
5. Hobart JC, Williams LS, Moran K, Thompson AJ. Quality of life measurement after stroke: uses and abuses of the SF-36. Stroke 2002, 33:1348-1356. 10.1161/01.STR.0000015030.59594.B3, 11988614.
6. Anderson C, Laubscher S, Burns R. Validation of the Short Form 36 (SF-36) Health Survey questionnaire among stroke patients. Stroke 1996, 27:1812-1816.
7. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990, 47:533-543.
8. Schulz M, Verheyen F, Mühlig S, Müller JM, Mühlbauer K, Knop-Schneickert E, Petermann F, Bergmann KC. Pharmaceutical Care Services for Asthma patients: a controlled intervention study. J Clin Pharmaol 2001, 41:668-676.
9. Paulos CP, Nygren CEA, Celedon C, Carcamo CA. Impact of a Pharmaceutical Care Program in a Community Pharmacy on Patients with Dyslipidemia. Ann Pharmacother 2005, 39:939-943. 10.1345/aph.1E347, 15827075.
10. Carretero OA, Oparil S. Essential Hypertension: Part I: Definition and Etiology. Circulation 2000, 101:329-335.
11. Craig ME, Hattersley A, Donaghue KC. Definition, epidemiology and classification of diabetes in children and adolescents. Pediatric Diabetes 2009, 10(Suppl 12):3-12. 10.1111/j.1399-5448.2009.00568.x, 19754613.
12. Ballantyne CM, O'Keefe JH, Gotto AM. Overview of Atherosclerosis and Dyslipidemia. Dyslipidemia & Atherosclerosis Essentials 2009, Chapter 1:5. Physicians's Press. Sudbury, MA: Jones and Bartlett, Fourth.
13. Suenkeler IH, Nowak M, Misselwitz B, Kugler C, Schreiber W, Oertel W, Back T. Timecourse of health-related quality of life as determined 3, 6 and 12 months after stroke. Relationship to neurological deficit, disability and depression. J Neurol 2002, 249:1160-1167. 10.1007/s00415-002-0792-3, 12242533.
14. Hackett ML, Duncan JR, Anderson CS, Broad JB, Bonita R. Health-related quality of life among long-term survivors of stroke: results from the Auckland Stroke Study, 1991-1992. Stroke 2000, 31:440-447.
15. Mangiapane S, Schulz M, Muhlig S, Ihle P, Schubert I, Waldmann H. Community pharmacy-based pharmaceutical care for asthma patients. Ann Pharmacother 2005, 39:1817-1822. 10.1345/aph.1G180, 16219893.
16. Cote I, Moisan J, Chabot I, Gregoire J-P. Health-related quality of life in hypertension: impact of a pharmacy intervention programme. Journal of Clinical Pharmacy and Therapeutics 2005, 30:355-362. 10.1111/j.1365-2710.2005.00663.x, 15985049.
17. Graesel E, Biehler J, Schmidt R, Schupp W. Intensification of the transition between inpatient neurological rehabilitation and home care of stroke patients. Controlled clinical trial with follow-up assessment six months after discharge. Clinical Rehabilitation 2005, 19:725-736. 10.1191/0269215505cr900oa, 16250191.
18. Wee HL, Cheung YB, Li SC, Fong KY, Thumboo J. The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: Is the whole greater than the sum of its parts?. Health and Quality of Life Outcomes 2005, 3:2. 10.1186/1477-7525-3-2, 548134, 15644146.